Data: 08/08/2026
Total encontrado: 9
1/9US=34 / Câncer
Rocha JCC. Oncogenética e medicina genômica. In: Guimarães JRQ. Manual de oncologia. 3ª ed. São Paulo: BBS Editora, 2008. p. 97-107.

ONCOGENETICA; PROCESSO DE CARCINOGENESE; PAPEL DO GENETICISTA; ACONSELHAMENTO GENETICO ONCOLOGICO; SINDROMES DE CANCER HEREDITARIO; TESTE GENETICO; MEDICINA GENOMICA; MEDICINA PERSONALIZADA; DIAGNOSTICO MOLECULAR DAS NEOPLASIAS; TOXICIDADE A QUIMIOTERAPIA E RADIOTERAPIA; DROGAS ALVO-ESPECIFICAS; PROGRAMAS DE PREVENCAO AO CANCER INDIVIDUALIZADOS


2/9US=33 / Câncer
Cheng L, Zbang S, Davidson DD, Montironi R, Lopez-Beltran A. Implications of cancer stem cells for cancer therapy. In: Bagley RG, Teicher BA. Stem cells and cancer. New York: Humana Press, 2009. p. 255-62. ISBN 978-1-60327-932-1.

CELULAS-TRONCO DO CANCER; VIA DE SEGMENTACAO; TERAPIA-ALVO; MEDICINA PERSONALIZADA; CELULA-TRONCO MESENQUIMAL; BIOLOGIA ESTROMAL


3/9US=87 / Biol/Mol
Ghadimi BM, Grade M. Cancer gene profiling for response prediction. In: Grützmann R, Pilarsky C. Cancer gene profiling: methods and protocols. New York: Humana Press, 2009. p. 327-39. (Methods in Molecular Biology, 576) ISBN 978-1-934115-76-3.

PERFIL DE EXPRESSAO GENICA; MICROARRAYS; CANCER RETAL; QUIMIORRADIOTERAPIA PRE-OPERATORIO; PREVISAO DE RESPOSTA; MEDICINA PERSONALIZADA


4/9US=35 / Biol/Mol
Mendelsohn J, Powis G. From bench to bedside with targeted therapies. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 521-30. ISBN 978-1-4160-3703-3.

TERAPIA ALVO MOLECULAR; MEDICINA PERSONALIZADA


5/9US=23-A / Câncer
Welsh SJ, Powis G. Personalized medicine for cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 93-107. ISBN 978-1-4020-8441-62.

CANCER; MEDICINA PERSONALIZADA


6/9US=56 / Biol/Mol
Brower SL, Fensterer JE, Bush JE. The chemoFx assay: an ex vivo chemosensitivity and resistance assay for predicting patient response to cancer chemotherapy. In: Mor G, Alvero AB. Apoptosis and cancer: methods and protocols. New Jersey: Humana Press, 2008. p. 57-78. (Methods in Molecular Biology) ISBN 978-1-58829-457-9.

ENSAIO CHEMOFX; ENSAIO EX VIVO; QUIMIOSENSIBILIDADE; QUIMIOTERAPIA; QUIMIOSSENSIBILIDADE E RESISTENCIA; CULTURA DE TECIDO PRIMARIO; MEDICINA PERSONALIZADA; CANCER


7/9US=69 / Câncer
Welsh SJ, Powis G. Toward personalized therapy for cancer. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 411-25. ISBN 978-1-60327-423-4.

TERAPIA PERSONALIZADA PARA O CANCER; CANCER; MEDICINA PERSONALIZADA; TERAPIA INDIVIDUALIZADA; FARMACOGENOMICA; TERAPIA-ALVO; ALVOS MOLECULARES


8/9US=80 / Biol/Mol
Jain KK. Tumor proteomics: oncoproteomics for personalized management of cancer. In: Daoud SS. Cancer proteomics from bench to bedside. New Jersey: Humana press, 2008. p. 81-99. (Cancer Drug Discovery and Development) ISBN 978-1-59745-169-7.

MICROARRAYS DE PROTEINA; DROGAS ANTICANCER; BIOMARKETING; CANCER; ONCOPROTEOMICS; MEDICINA PERSONALIZADA; FARMACOGENOMICA; PHARMACOPROTEOMICS; PERFIL DE PROTEINAS; PROTEOMICA


9/9US=47 / Biol/Mol
McCullough K. Personalized medicine. In: Coleman WB, Tsongalis GJ. Molecular diagnostics: for the clinical laboratorian. 2ª ed. Totowa: Humana Press, 2006. p. 341-6. ISBN 1-58829-356-4.

DIAGNOSTICO MOLECULAR; MEDICINA PERSONALIZADA; METABOLISMO DE MEDICAMENTOS; DISTRIBUICAO DE MEDICAMENTOS; ALVOS DE MEDICAMENTOS; FARMACOGENETICA